4 results
Industry
PROJECT NUMBER • 2017-117
PROJECT STATUS:
COMPLETED

Identification of differentially expressed innate immune genes in the New Zealand paua (Haliotis iris) and the Australian hybrid abalone (H. laevigata X H. rubra) upon immersion challenge with the abalone herpesvirus-1 (HaHV)

This project was carried out by scientists from AAHL CSIRO (Dr Serge Corbeil) and from LaTrobe University (Drs Karla Helbig and Subir Sarker). After discovering the existence of an abalone species (Päua - Haliotis iris) resistant to AVG our research team based in Geelong and Melbourne...
ORGANISATION:
CSIRO Australian Animal Health Laboratory

Aquatic Animal Health and Biosecurity Coordination Program: strategic planning, project management and adoption

Project number: 2020-052
Project Status:
Current
Budget expenditure: $605,748.56
Principal Investigator: Nicholas J. Moody
Organisation: CSIRO Australian Animal Health Laboratory
Project start/end date: 23 Jun 2022 - 31 May 2026
Contact:
FRDC

Need

Australia’s aquatic animals are free from many diseases that occur overseas, providing us with a competitive advantage in both production and trade. Australian aquaculture has grown from an industry valued at AU$260 million in 1993 to an industry valued at AU$1.6 billion in 2020 (ABARES, 2021). This dramatic growth has been accompanied by the emergence of new diseases/infectious agents, e.g., NNV since 1989, Bonamia since 1992, OOD since 2006, OsHV since 2010, POMV since 2012, new YHV genotypes since 2013, PMMS since 2015 and WSD since 2016, all of which threaten the sustainability of major aquaculture enterprises. Consequently, the need for health research to support this expanding sector is also growing. The wild-harvest, recreational, Indigenous and ornamental sectors are also under threat; e.g., crayfish plague, Edwardsiella ictaluri in catfish, Perkinsus in oysters, WSD in crustacea and gourami iridovirus in a range of finfish species pose significant risks.

Thus, identification and prioritisation of aquatic animal health and biosecurity research and capacity building needs to be coordinated across all aquatic sectors to ensure synergy while avoiding duplication. FRDC, through AAHBRCP, plays a major role in addressing research needs and training in aquatic animal health and biosecurity and is able to direct funding priorities to the most pressing areas. AAHBRCP provides a cohesive national approach to FRDC-supported R&D by providing leadership, direction and focus for health R&D and other related non-R&D activities. According to an external review of AAHBRCP undertaken in 2015 the consensus among major stakeholders was that AAHBRCP provides an essential service for the aquatic animal sector. Given the success of the AAHBRCP there is a need to continue it as a means of providing the service with consideration given to adjustments (reflected in this proposal) to enhance the service it provides for the evolving needs of Australia’s seafood industry, public policy and program needs

Objectives

1. In consultation with key stakeholders (industry, government, aquatic animal health providers and industry representatives) identify and prioritise R&D needed to deliver national, jurisdictional and industry sector aquatic animal health and biosecurity related planning objectives
2. Promote and manage aquatic animal health and biosecurity training and capacity building
3. Facilitate the dissemination of outputs (information and results) from R&D projects to key stakeholders
4. Through the biannual AAHBRCP scientific conference, cultivate research community collaboration, engagement, and foster early career researchers.
Environment
PROJECT NUMBER • 2004-217
PROJECT STATUS:
COMPLETED

Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: development of an AGD vaccine: phase II

Amoebic gill disease (AGD) is considered to be the most significant health problem for farmed Atlantic salmon in Tasmania, costing the industry an estimated $15-20 million pa. It is caused by the presence of Neoparamoeba spp. on the gills and if untreated can lead to death. Although some control of...
ORGANISATION:
CSIRO Australian Animal Health Laboratory
Industry
PROJECT NUMBER • 2019-089
PROJECT STATUS:
COMPLETED

Evaluation of point of care (POC) tests for White Spot Syndrome Virus (WSSV)

The CSIRO Australian Centre for Disease Preparedness (ACDP) Fish Diseases Laboratory (AFDL), in collaboration with Biosecurity Queensland, conducted a laboratory-based evaluation of commercially available point-of-care (POC) tests designed to detect white spot syndrome virus (WSSV) in the field. The...
ORGANISATION:
CSIRO Australian Animal Health Laboratory
View Filter

Organisation